Connect Biopharma Holdings CNTB
NASDAQ CNTB
$2.06 +0.05 (+2.50%)
As of: Sep 10, 2026 · 3:59 PM EDT

Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026)

Connect Biopharma Holdings' (CNTB) quarterly Other Working Capital Changes came in at -$2.1 million in Q2 2026, down 194.63% year-over-year from $2.2 million in Q2 2025, and down 723.35% quarter-over-quarter from -$257000.0 in Q1 2026.

Analysis

Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026) Analysis & Trends

Connect Biopharma Holdings has disclosed Other Working Capital Changes across 3 years of filings, most recently posting -$2.1 million for Q2 2026.

  • In Q2 2026, Other Working Capital Changes fell 194.63% year-over-year to -$2.1 million; the TTM figure through Jun 2026 stood at -$1.8 million (down 159.79% YoY), while the FY2025 annual figure was $4.1 million, up 330.12% from the prior year.
  • Other Working Capital Changes came in at -$2.1 million for Q2 2026 at Connect Biopharma Holdings, down from -$257000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $2.2 million in Q2 2025 to a low of -$2.1 million in Q2 2026.
  • Average Other Working Capital Changes over 3 years is -$4900.0, with a median of -$149500.0 recorded in 2024.
  • Year-over-year, Other Working Capital Changes soared 5423.81% in 2025 and tumbled 194.63% in 2026.
  • Over 3 years, Other Working Capital Changes stood at -$2.0 million in 2024, then jumped by 39.42% to -$1.2 million in 2025, then sank by 72.73% to -$2.1 million in 2026.
  • Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2.1 million in Q2 2026, -$257000.0 in Q1 2026, and -$1.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Connect Biopharma Holdings 129.86 Mn 129.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.12 Mn
Jun 30, 2026 -2.12 Mn
Mar 31, 2026 -257,000.00
Mar 31, 2026 -257,000.00
Dec 31, 2025 -1.23 Mn
Dec 31, 2025 -1.23 Mn
Sep 30, 2025 1.81 Mn
Sep 30, 2025 1.81 Mn
Jun 30, 2025 2.24 Mn
Jun 30, 2025 2.24 Mn
Mar 31, 2025 1.29 Mn
Mar 31, 2025 1.29 Mn
Dec 31, 2024 -2.02 Mn
Dec 31, 2024 -2.02 Mn
Sep 30, 2024 1.49 Mn
Sep 30, 2024 1.49 Mn
Jun 30, 2024 -42,000.00
Jun 30, 2024 -42,000.00
Mar 31, 2024 -1.21 Mn
Mar 31, 2024 -1.21 Mn